ScienceWorkJoin
Nurix Therapeutics

Senior Scientist / Principal Scientist, Induced Proximity

$162,000 - $175,700/yearBrisbane, California11 days ago

Senior Scientist / Principal Scientist, Induced Proximity

The Opportunity

Nurix Therapeutics, Inc. is seeking a motivated scientist to support and help execute the non-degradative induced proximity research strategy. This individual will contribute hands-on scientific expertise to programs beyond targeted protein degradation, helping advance target validation, mechanism characterization, and candidate optimization efforts. Working closely with the Senior Vice President of Induced Proximity and cross-functional partners in chemistry, biology, and biochemistry, this person will help translate strategic priorities into experimental plans, generate and interpret data that inform go/no-go decisions, and contribute ideas on emerging modalities and technologies worth exploring. This is an opportunity to grow scientific and possibly future leadership experience within a fast-evolving area of drug discovery, with direct exposure to strategic decision-making at the platform level.

Responsibilities

  • Design, execute, and troubleshoot experiments at the bench; building and running biochemical, biophysical, and cell-based assays to interrogate induced proximity mechanisms and drive program decisions
  • Contribute to identification, validation, and prioritization of targets amenable to induced proximity approaches (protein sequestration, gene regulation, stabilizers, and related mechanisms)
  • Evaluate and integrate new and emerging induced proximity modalities into the strategic roadmap
  • Partner with computational/structural biology to advance rational design and predictive modeling of ternary complex formation
  • Present experimental data, interpretations, and recommendations to project teams and executive leadership
  • Ensure programs meet key milestones from discovery through candidate nomination and IND-enabling work
  • Stay current on the competitive and scientific landscape; publish/present externally to build company visibility as needed

Required Qualifications

  • Education: Ph.D. in biology, biochemistry, molecular biology, or a related field
  • Experience: 5+ years of relevant industry drug discovery experience, including significant direct work on induced proximity modalities (targeted protein degradation, molecular glues, bifunctional degraders, or similar)
  • Biophysical and biochemical assays: Hands-on assay development to quantify ternary complex formation and cooperativity (e.g. TR-FRET/HTRF, NanoBRET, AlphaLISA, SPR, ITC, MST, and DSF)
  • Biochemical assay development: Experience with relevant proximity-induced reactions (e.g. ubiquitination, phosphorylation, acetylation, etc.)
  • Cell-based mechanistic pharmacology: Western blot, HiBiT/NanoLuc kinetic readouts, flow cytometry, reporter assays, and dose–response and washout/resynthesis studies to establish on-target mechanism
  • Cell line engineering and functional genomics: CRISPR knockout/knock-in, CRISPRa/CRISPRi, and siRNA to validate targets and interrogate effector dependencies
  • Target engagement and protein-stability methods: CETSA, NanoBRET target engagement, co-IP/pulldown, and cycloheximide-chase or half-life measurement
  • Scientific knowledge: Deep mechanistic understanding of ternary complex biology and cooperativity, the ubiquitin–proteasome and autophagy–lysosomal pathways, non-degradative proximity mechanisms (protein sequestration, stabilization, induced phosphorylation/dephosphorylation, transcriptional regulation), and structure-based drug design
  • Data analysis: Rigorous experimental design and quantitative data analysis, including assay qualification and QC (e.g., Z′, dynamic range), curve fitting in GraphPad Prism or equivalent, screening-data handling (Genedata Screener or similar), and disciplined ELN documentation
  • Collaboration: Strong track record of cross-functional collaboration (biology, chemistry, DMPK)
  • Communication: Excellent scientific communication skills, including experience presenting to senior leadership

Preferred Qualifications

  • Ph.D. in a relevant scientific field (Biochemistry, Biology, chemical biology, etc.) with 4 or more years of relevant post-graduate industry or academic research experience, or MS with 8 or more years of relevant industry experience
  • Publication record and/or patents in induced proximity or targeted degradation space
  • Experience with computational tools for ternary complex prediction or AI/ML-driven drug design
  • Familiarity with a broad range of non-degradative modalities beyond classical bifunctional degraders (e.g., glues, LYTACs, AUTACs, MrTACs, RIPTACs, TCIPs, Tracers, DACs)

Culture and Values

  • Ability to work collaboratively across multiple groups within the organization
  • Excellent organization and communication with effective presentation skills
  • Self-driven and enthusiastic with proficiencies to deliver in a dynamic environment
  • Curious mindset with a willingness and flexibility to learn new skills
  • High level of creativity and productivity with strong problem-solving skills

Compensation and Location

Salary Range: $162,000 - $175,700 (Senior Scientist), $187,700 - $208,600 (Principal Scientist)

The posted range applies to roles based in the San Francisco Bay Area and reflects local market conditions. Where an offer lands within that range depends on the candidate's relevant experience, technical expertise, and how their background aligns with the role's requirements.

Location: Onsite – Brisbane, CA

About Nurix Therapeutics

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease.

About Nurix Therapeutics

Nurix Therapeutics is a clinical-stage biopharmaceutical company developing targeted protein degradation therapies for cancer and inflammatory diseases. The company uses its DEL-AI discovery platform to discover and develop degraders and degrader-antibody conjugates designed to eliminate disease-causing proteins.

Industry
Biopharmaceuticals
Head office
San Francisco, California, United States
Company size
301-500
Founded
2009
Targeted protein degradationDegrader-Antibody Conjugates (DACs)DEL-AI discovery engineOncology therapeuticsImmunology therapeuticsNeurology therapeutics
See all 17 jobs at Nurix Therapeutics→

Interested in this role?

Apply now to join Nurix Therapeutics.

Similar roles

Let employers come to you

Upload your CV and we build your profile from it. Employers contact you. Free for job seekers.

Create your profile
Free email alerts

Be the first to know.

New science jobs, employers and talent, straight to you as they go live. Stay in the loop.

Get the inside track →

Senior Scientist / Principal Scientist, Induced Proximity